Thrombospondin-derived Peptide; Cyclic CSVTCG

This peptide is derived from thrombospondin and represents a binding motif responsible for thrombospondin-CD36 interaction. It is cyclized through a disulfide bond. Thrombospondin is a matrix-bound glycoprotein involved in cancer metastasis, tumor adhesion, and angiogenesis. This peptide has been shown to competitively inhibit platelet aggregation and tumor metastasis.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	X21211
M.W/Mr.	566.7
Sequence	One Letter Code: CSVTCG (S-S Bonded) Three Letter Code: H-Cys-Ser-Val-Thr-Cys-Gly-OH(S-S Bonded)

CAT#	Product Name	Inquiry
CR00029	Ac-Lys-Gln-Leu-Arg-AFC	Inquiry
CR00032	Tumor Targeted Pro-Apoptotic Peptide	Inquiry
CR00022	LIP2 (human)	Inquiry
H2605	Hippuryl-Lys-Val-OH	Inquiry
C06019	Calcitonin N-Terminal Flanking Peptide, human, N-Procalcitonin	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.